Quarterly Consolidated Statement Of Cash Flows

KOBAYASHI PHARMACEUTICAL CO.,LTD. - Filing #7727278

Concept 2017-01-01 to
2017-12-31
As at
2017-12-31
2016-04-01 to
2016-12-31
As at
2016-12-31
As at
2016-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
27,990,000,000 JPY
19,294,000,000 JPY
Interest and dividends received
675,000,000 JPY
528,000,000 JPY
Interest paid
-27,000,000 JPY
-21,000,000 JPY
Income taxes paid
-6,287,000,000 JPY
-3,703,000,000 JPY
Net cash provided by (used in) operating activities
22,350,000,000 JPY
16,097,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,841,000,000 JPY
-2,850,000,000 JPY
Proceeds from sale of property, plant and equipment
3,000,000 JPY
6,000,000 JPY
Purchase of investment securities
-1,064,000,000 JPY
-18,000,000 JPY
Proceeds from sale of investment securities
715,000,000 JPY
315,000,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
JPY
-2,469,000,000 JPY
Other, net
-50,000,000 JPY
0 JPY
Net cash provided by (used in) investing activities
7,039,000,000 JPY
-519,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-5,068,000,000 JPY
-8,054,000,000 JPY
Dividends paid
-4,343,000,000 JPY
-3,919,000,000 JPY
Net cash provided by (used in) financing activities
-9,162,000,000 JPY
-11,922,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
137,000,000 JPY
-760,000,000 JPY
Net increase (decrease) in cash and cash equivalents
20,365,000,000 JPY
2,894,000,000 JPY
Cash and cash equivalents
48,688,000,000 JPY
28,322,000,000 JPY
25,428,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.